Next Article in Journal
Early Real-World Data to Assess Benefits and Risks of COVID-19 Vaccines: A Systematic Review of Methods
Next Article in Special Issue
Augmenting Vaccine Efficacy against Delta Variant with ‘Mycobacterium-w’-Mediated Modulation of NK-ADCC and TLR-MYD88 Pathways
Previous Article in Journal
Overcoming Aging-Associated Poor Influenza Vaccine Responses with CpG 1018 Adjuvant
Previous Article in Special Issue
Maintenance of Antibody Response in Egyptian Healthcare Workers Vaccinated with ChAdOx1 nCoV-19 Vaccine during Delta and Omicron Variants Pandemic: A Prospective Study
 
 
Brief Report

Article Versions Notes

Vaccines 2022, 10(11), 1895; https://doi.org/10.3390/vaccines10111895
Action Date Notes Link
article xml file uploaded 10 November 2022 08:20 CET Original file -
article xml uploaded. 10 November 2022 08:20 CET Update https://www.mdpi.com/2076-393X/10/11/1895/xml
article pdf uploaded. 10 November 2022 08:20 CET Version of Record https://www.mdpi.com/2076-393X/10/11/1895/pdf
article supplementary file uploaded. 10 November 2022 08:20 CET - https://www.mdpi.com/2076-393X/10/11/1895#supplementary
article html file updated 10 November 2022 08:21 CET Original file -
article html file updated 2 March 2023 22:14 CET Update https://www.mdpi.com/2076-393X/10/11/1895/html
Back to TopTop